Rheumatology Network's Top 5: February 25, 2022
Take 5 minutes to catch up on Rheumatology Network's highlights from the week ending February 25, 2021.
Overdrive Podcast: Efficacy of Guselkumab for Treating Psoriatic Arthritis
On this month's episode of Overdrive, Rheumatology Network interviewed Terence Rooney, MD, to discuss the findings of a network meta-analysis that examined the efficacy of guselkumab (TREMFYA) for skin clearance and joint improvements in patients with psoriatic arthritis.
Roy Fleischmann, MD: The Safety of JAK Inhibitors
Roy Fleishmann, MD, discusses his Rheumatology Winter Clinical Symposium presentation, “Beyond the package insert: JAK inhibitors (jakinibs): safety issues.”
Rheumatoid Arthritis Quiz: COVID-19 Vaccine Booster
The American College of Rheumatology has recently updated its recommendations on COVID-19 booster vaccines. Test your knowledge of the latest advice on COVID-19 boosters and how they should be administered with this quiz.
Study Supports Renal Biomarker Candidate for Proliferative Lupus Nephritis Chronicity
Study provides supportive data to confirm the pathogenic role of NEU1 in proliferative lupus nephritis.
Anisha Dua, MD, MPH: What’s New in Vasculitis?
Anisha Dua, MD, MPH, discusses the mimics, related conditions, and new diseases in the field of vasculitis as it relates to rheumatology.
